ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$RVTY:NYSE · REVVITY INC

Sector: health

Conviction from: S&PCitrini

52-week range: 81.22171.74

Revvity, formerly PerkinElmer, provides life sciences and diagnostics products and services, including reagents, instruments, and testing solutions for research and healthcare.

3 tracked filer(s) hold this · 2 opened, 1 added, 0 trimmed in 30-SEP-2026

Aggregate 13FScore 53 — mean of 3 scored holder(s) · buyers (new/add) avg 53. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Larry Robbins / Glenview61New buy6,000$917,3400.0%
Ancora42New buy85$12,9960.0%
Bridgewater55Added +724%198,993$30,424,0400.1%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

1 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-10-27Gilbert Cisneros CA31SELL$1,001 - $15,000PTR

Trump & executive branch trades all Trump/exec trades →

1 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-07-01Trump, Donald J PresidentSELL$15,001 - $50,000PTR

Citrini Research coverage report library →

ReportDateStance
#135 — State of the Themes: The End of the Trade (As We Know It)2026-11-04LONG
#134 — Citrini Therapeutics: We Wanted to Use Claude to Create a New Drug2026-10-20LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.